Mp29-09 Novel Selective Lysine Specific Demethylase 1 Inhibitors Effectively Impair Castration Resistant Prostate Cancer Growth

Journal of Urology - Netherlands
doi 10.1016/j.juro.2018.02.929
Full Text
Abstract

Available in full text

Categories
Urology
Date
Authors
Publisher

Ovid Technologies (Wolters Kluwer Health)

Related search

Mp83-03 Novel Selective Lysine Specific Demethylase 1 Inhibitors Effectively Impair Castration Resistant Prostate Cancer Growth

Journal of Urology
Urology
2017English

Mp62-03 Novel Selective Lysine-Specific Demethylase 1 Inhibitors and Autophagy Inhibitors Effectively Impair Castration-Resistant Prostate Cancer Growth

Journal of Urology
Urology
2016English

Pcn346 - Disease Specific Cost Analysis of the Nonmetastatic Castration-Resistant Prostate Cancer and Metastatic Castration-Resistant Prostate Cancer Health States

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Prostate-Specific Membrane Antigen–Directed Therapy for Metastatic Castration-Resistant Prostate Cancer

Cancer Journal
Cancer ResearchOncology
2016English

Structure Activity Relationship and Modeling Studies of Inhibitors of Lysine Specific Demethylase 1

PLoS ONE
Multidisciplinary
2017English

Development of (4-Cyanophenyl)glycine Derivatives as Reversible Inhibitors of Lysine Specific Demethylase 1

Journal of Medicinal Chemistry
Drug DiscoveryMolecular Medicine
2017English

Lysine-Specific Demethylase 1 Promotes Tumorigenesis and Predicts Prognosis in Gallbladder Cancer

Oncotarget
Oncology
2015English

Resistance to Novel Antiandrogen Therapies in Metastatic Castration-Resistant Prostate Cancer

Clinical Medicine Insights: Oncology
Oncology
2016English

Aggressive Variants of Castration-Resistant Prostate Cancer

Clinical Cancer Research
Cancer ResearchOncology
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy